Inicio › Osteosarcoma › Nueva York
Ensayos clínicos de Osteosarcoma en Nueva York
11 estudios sobre Osteosarcoma buscan participantes en Nueva York.
Ciudades en Nueva York
Texto oficial del estudio (inglés)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- New York Medical College, Valhalla
ReclutandoFase 2
Edades de 12 a 39 · Todos los sexos · Actualizado el 29 sept 2026 · NCT04616560Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Montefiore Medical Center, The Bronx
ReclutandoFase 1/2
Edades de 12 a 40 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07725380Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
ReclutandoFase 1/2
12 Months – 30 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- y 11 más
ReclutandoFase 3
Hasta los 50 · Todos los sexos · Actualizado el 25 ago 2026 · NCT05235165SPEARHEAD-3 Pediatric Study
- Memorial Sloan Kettering Kids, New York
ReclutandoFase 1/2
Edades de 2 a 21 · Todos los sexos · Actualizado el 11 ago 2026 · NCT05642455Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- y 1 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 18 may 2026 · NCT01790152Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
- Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- Memorial Sloan Kettering at Nassau (Consent and Followup), Uniondale
ReclutandoEstudio observacional
Edades de 4 en adelante · Todos los sexos · Actualizado el 17 abr 2026 · NCT03442465A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
- Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- y 1 más
ReclutandoFase 2
Edades de 6 a 49 · Todos los sexos · Actualizado el 17 mar 2026 · NCT07477457Upfront Surgical Resection for Osteosarcoma
- Montefiore Medical Center, The Bronx
ReclutandoEstudio observacional
Edades de 5 a 40 · Todos los sexos · Actualizado el 16 mar 2026 · NCT06384404Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
ReclutandoFase 2
Edades de 1 a 50 · Todos los sexos · Actualizado el 13 mar 2026 · NCT01804634A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
ReclutandoFase 2
18 Months – 40 Years · Todos los sexos · Actualizado el 12 ago 2025 · NCT05135975De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.